Role of intrathecal nalbuphine on prevention of postspinal shivering after knee arthroscopy
Not Applicable
Completed
- Conditions
- Surgerynalbuphine, shiveringAnaesthesia
- Registration Number
- PACTR201505001091143
- Lead Sponsor
- menofiya university hospital
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- All
- Target Recruitment
- 60
Inclusion Criteria
20-60 years of both sex and ASA(American Society of Anesthesia) physical status I or II scheduled for knee arthroscopy under spinal anaesthesia
Exclusion Criteria
Patients with contraindications to regional anaesthesia, allergy to the study medication, obese with body mass index (BMI) >30 were excluded.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie nalbuphine's antishivering effects in postspinal anesthesia?
How does intrathecal nalbuphine compare to intravenous meperidine for postspinal shivering prevention?
Are there specific biomarkers that predict nalbuphine efficacy in orthopedic surgery patients?
What adverse events are associated with intrathecal nalbuphine use in knee arthroscopy procedures?
How do opioid receptor modulators like nalbuphine compare to non-opioid approaches for postoperative shivering?